14 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Summary Table ... GLP-1 receptor agonists ... #comparison #management ... #endocrinology ... #dm2
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
Hyperglycemic Hyperosmolar Syndrome ... , food binges, etc ... pathophysiology #comparison ... #endocrinology ... #diabetes #diabetic
Hyperglycemia - Differential Diagnosis Algorithm
Diabetes Mellitus:
 • Impaired Glucose Tolerance
 • Type I Diabetes
 • Type
• Cushing's Syndrome ... diuretics • Beta agonists ... Hyperglycemia (e.g ... Diagnosis #Algorithm #endocrinology ... #causes
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Medication Guide Classes ... GLP-1 receptor agonist ... #Mellitus #DM2 ... #pharmacology #comparison ... #table #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... Ozempic), or daily tablet ... side effects (e.g ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
A toxidrome is a syndrome (set of symptoms) caused by specific medications or toxins.

There are 5
toxidrome is a syndrome ... set of symptoms) caused ... Cholinergic: ACh recptor agonists ... Toxicology #Toxidromes #Comparison ... #Table #Anticholinergics
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
Januvia) - Once/day tablet ... GLP-I receptor agonist ... not definitively cause ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
• Nephrogenic diabetes ... Kidney stones caused ... V1 receptor-agonist ... Tolvaptan) • Treatment ... #Medications #Table
Stiff Person Syndrome (SPS) - Diagnosis and Management Summary

Epidemiology:
 • Prevalence: 1-2 cases per million -
Prevalence: 1-2 cases ... associated with DM ... contractions (agonist ... Treatment: • ... Diagnosis #Management #treatment
Causes of Hypokalemia
Transcellular Shifts:
 - Alkalosis, Increased plasma insulin (treatment of diabetic ketoacidosis), ß-Adrenergic agonists, Hypokalemic
Causes of Hypokalemia ... plasma insulin (treatment ... of diabetic ketoacidosis ... , ß-Adrenergic agonists ... #Hypokalemia #Causes